JavaScript seems to be disabled in your browser. You must have JavaScript enabled in your browser to utilize the functionality of this website.
Description: GNF-5837 (GNF5837) is an orally bioavailable pan-TRK (TrkA, TrkB) inhibitor with potential antitumor activity. It inhibits TrkA/B with IC50s of 8 nM, and 12 nM, respectively. GNF-5837 demonstrates high anti-proliferative activity in vitro against Ba/F3 cells with an IC50 of 0.042 uM. GNF-5837 shows high in vivo antitumor efficacy in a mouse xenograft model derived from RIE cells expressing both TRKA and NGF.
References: ACS Med Chem Lett. 2012 Jan 1; 3(2):140-5.
Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.
All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.
Request Data Sheet
Request product datasheet
Request safety datasheet
Compare
Add to wishlist
Get an offer
Request delivery time
Ask a technical question
Submit a bulk request
sales@hoelzel.de
« Back
Subscribe, get 15% off every fifth order and have your items delivered on time!
Forgot Your Password?
Not yet registered? Create account here!